A scientific panel that shaped the government's policy for testing the safety and effectiveness of painkillers was funded by major pharmaceutical firms seeking to affect the thinking of the FDA.
Pharmaceutical firms paid to attend meetings of panel that advises FDA
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.